|
Management of edema in patients with serum albumin level above 2 g/dL
|
73 (24.58)
|
Ability to tolerate an oral PPI
|
246 (53.02)
|
|
A component of parenteral nutrition
|
59 (19.87)
|
Presence of only one minor risk factor for stress-related mucosal damage prophylaxis
|
115 (24.78)
|
|
Monotherapy of edema without a loop diuretic
|
36 (12.12)
|
Treatment of acute pancreatitis
|
29 (6.25)
|
|
Therapeutic paracentesis with ascitic fluid removal less than 5 L
|
21 (7.07)
|
Treatment of acute cholangitis or cholecystitis
|
21 (4.53)
|
|
Monotherapy of hepatorenal syndrome without a vasoactive agent
|
17 (5.72)
|
Gastric and/or pancreas cancer
|
17 (3.66)
|
|
Prolonged prevention (more than 2 weeks) of cerebral vasospasm in patients with subarachnoid hemorrhage
|
11 (3.7)
|
Lower GI obstruction or bleeding
|
15 (3.23)
|
|
Non-ARDS condition
|
3 (1.01)
|
Non-refractory (mild) dyspepsia
|
9 (1.94)
|
|
Others (no specific explanation)
|
42 (14.14)
|
Others (no specific explanation)
|
12 (2.59)
|
